204 related articles for article (PubMed ID: 23260601)
1. Phase I clinical trial of valacyclovir and standard of care cyclophosphamide in children with endemic Burkitt lymphoma in Malawi.
Olson D; Gulley ML; Tang W; Wokocha C; Mechanic O; Hosseinipour M; Gold SH; Nguluwe N; Mwansambo C; Shores C
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):112-8. PubMed ID: 23260601
[TBL] [Abstract][Full Text] [Related]
2. The role of valacyclovir on Epstein-Barr virus viral loads in pediatric liver transplantation patients.
Ozçay F; Arslan H; Bilezikçi B; Sevmiş S; Moray G; Haberal M
Transplant Proc; 2009 Sep; 41(7):2878-80. PubMed ID: 19765462
[TBL] [Abstract][Full Text] [Related]
3. A six-month trial of valacyclovir in the Epstein-Barr virus subset of chronic fatigue syndrome: improvement in left ventricular function.
Lerner AM; Beqaj SH; Deeter RG; Dworkin HJ; Zervos M; Chang CH; Fitzgerald JT; Goldstein J; O'Neill W
Drugs Today (Barc); 2002 Aug; 38(8):549-61. PubMed ID: 12582420
[TBL] [Abstract][Full Text] [Related]
4. Long-term administration of valacyclovir reduces the number of Epstein-Barr virus (EBV)-infected B cells but not the number of EBV DNA copies per B cell in healthy volunteers.
Hoshino Y; Katano H; Zou P; Hohman P; Marques A; Tyring SK; Follmann D; Cohen JI
J Virol; 2009 Nov; 83(22):11857-61. PubMed ID: 19740997
[TBL] [Abstract][Full Text] [Related]
5. Viral response to chemotherapy in endemic burkitt lymphoma.
Tang W; Harmon P; Gulley ML; Mwansambo C; Kazembe PN; Martinson F; Wokocha C; Kenney SC; Hoffman I; Sigel C; Maygarden S; Hoffman M; Shores C
Clin Cancer Res; 2010 Apr; 16(7):2055-64. PubMed ID: 20233888
[TBL] [Abstract][Full Text] [Related]
6. Valacyclovir pharmacokinetics and exploratory pharmacodynamics in young adults with Epstein-Barr virus infectious mononucleosis.
Vezina HE; Balfour HH; Weller DR; Anderson BJ; Brundage RC
J Clin Pharmacol; 2010 Jul; 50(7):734-42. PubMed ID: 19897764
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus replication in oral hairy leukoplakia: response, persistence, and resistance to treatment with valacyclovir.
Walling DM; Flaitz CM; Nichols CM
J Infect Dis; 2003 Sep; 188(6):883-90. PubMed ID: 12964120
[TBL] [Abstract][Full Text] [Related]
8. Antiviral agents for infectious mononucleosis (glandular fever).
De Paor M; O'Brien K; Fahey T; Smith SM
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD011487. PubMed ID: 27933614
[TBL] [Abstract][Full Text] [Related]
9. Valacyclovir versus acyclovir for HSV prophylaxisin neutropenic patients.
Warkentin DI; Epstein JB; Campbell LM; Yip JG; Cox VC; Ransier A; Barnett MJ; Marra F
Ann Pharmacother; 2002 Oct; 36(10):1525-31. PubMed ID: 12243600
[TBL] [Abstract][Full Text] [Related]
10. Open-label study of valacyclovir 1.5 g twice daily for the treatment of uncomplicated herpes zoster in immunocompetent patients 18 years of age or older.
Madkan VK; Arora A; Babb-Tarbox M; Aboutlabeti S; Tyring S
J Cutan Med Surg; 2007; 11(3):89-98. PubMed ID: 17511925
[TBL] [Abstract][Full Text] [Related]
11. A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group.
Tyring SK; Douglas JM; Corey L; Spruance SL; Esmann J
Arch Dermatol; 1998 Feb; 134(2):185-91. PubMed ID: 9487210
[TBL] [Abstract][Full Text] [Related]
12. Single-day, patient-initiated famciclovir therapy versus 3-day valacyclovir regimen for recurrent genital herpes: a randomized, double-blind, comparative trial.
Abudalu M; Tyring S; Koltun W; Bodsworth N; Hamed K
Clin Infect Dis; 2008 Sep; 47(5):651-8. PubMed ID: 18637755
[TBL] [Abstract][Full Text] [Related]
13. Long term survival of children with Burkitt lymphoma in Malawi after cyclophosphamide monotherapy.
Kazembe P; Hesseling PB; Griffin BE; Lampert I; Wessels G
Med Pediatr Oncol; 2003 Jan; 40(1):23-5. PubMed ID: 12426682
[TBL] [Abstract][Full Text] [Related]
14. Anti-viral prophylaxis reduces the incidence of lymphoproliferative disease in lung transplant recipients.
Malouf MA; Chhajed PN; Hopkins P; Plit M; Turner J; Glanville AR
J Heart Lung Transplant; 2002 May; 21(5):547-54. PubMed ID: 11983544
[TBL] [Abstract][Full Text] [Related]
15. Valomaciclovir versus valacyclovir for the treatment of acute herpes zoster in immunocompetent adults: a randomized, double-blind, active-controlled trial.
Tyring SK; Plunkett S; Scribner AR; Broker RE; Herrod JN; Handke LT; Wise JM; Martin PA;
J Med Virol; 2012 Aug; 84(8):1224-32. PubMed ID: 22711350
[TBL] [Abstract][Full Text] [Related]
16. In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study.
Leruez-Ville M; Ghout I; Bussières L; Stirnemann J; Magny JF; Couderc S; Salomon LJ; Guilleminot T; Aegerter P; Benoist G; Winer N; Picone O; Jacquemard F; Ville Y
Am J Obstet Gynecol; 2016 Oct; 215(4):462.e1-462.e10. PubMed ID: 27083761
[TBL] [Abstract][Full Text] [Related]
17. Pilot study of sodium phenylbutyrate as adjuvant in cyclophosphamide-resistant endemic Burkitt's lymphoma.
Phillips JA; Griffin BE
Trans R Soc Trop Med Hyg; 2007 Dec; 101(12):1265-9. PubMed ID: 17915270
[TBL] [Abstract][Full Text] [Related]
18. Valacyclovir-associated neurotoxicity in peritoneal dialysis patients.
Chaudhari D; Ginn D
Am J Ther; 2014; 21(6):e215-7. PubMed ID: 23528373
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and safety of valaciclovir in children with Epstein-Barr virus illness.
Simon MW; Fish DN; Deeter RG
Drugs R D; 2002; 3(6):365-73. PubMed ID: 12516939
[TBL] [Abstract][Full Text] [Related]
20. The renal safety of high doses of valacyclovir for prevention of cytomegalovirus infection after renal transplantation.
Le Meur Y; Mons S; Moesch C; Leroux-Robert C
Nephrol Dial Transplant; 2000 Mar; 15(3):442. PubMed ID: 10692544
[No Abstract] [Full Text] [Related]
[Next] [New Search]
